Project Number 1R44AG077991-01A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for A 26-week rat toxicity study and efficacy and biomarker studies in Tau-APP Alzheimer's mouse model to support a Phase 1b clinical study Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator MOE, JAMES G Principal Investigator First Name JAMES Principal Investigator Last Name MOE Awardee Organization OLIGOMERIX, INC Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $1,124,972 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE